Exploration of Continuous Glucose Monitoring on the Intensive Care Unit

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 17, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Hypoglycemia, Hyperglycemia
Interventions
DEVICE

Continuous glucose monitoring (CGM) device

All included study participants recieve a CGM sensor (Dexcom G7) to monitor blood glucose. The treatment team is blind for the CGM values; the gold standard for glucose control (POC interval measures) will be followed.

Trial Locations (3)

7609 PP

Zorggroep Twente Almelo, Almelo

7416SE

Deventer Ziekenhuis, Deventer

7512 KZ

Medisch Spectrum Twente, Enschede

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

DexCom, Inc.

INDUSTRY

collaborator

Pioneers in Healthcare

UNKNOWN

lead

Kim Kamphorst

OTHER

NCT06645873 - Exploration of Continuous Glucose Monitoring on the Intensive Care Unit | Biotech Hunter | Biotech Hunter